Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: A case report and a simplified diagnostic flowchart for diagnosis and treatment of sarcoidosis
- PMID: 27752465
- PMCID: PMC5061085
- DOI: 10.1016/j.rmcr.2016.09.006
Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: A case report and a simplified diagnostic flowchart for diagnosis and treatment of sarcoidosis
Abstract
The diagnosis of sarcoidosis in a patient living with HIV infection is an uncommon event and a challenge for clinicians. Clinical manifestations are variable and fluctuating depending to adherence to ARV therapy and to the level of CD4 count. We analyze here one chronic case in which sarcoidosis appeared clinically two years after pulmonary tuberculosis. The course of the disease was influenced and prolonged by frequent interruptions of antiretroviral therapy. Moreover the diagnosis and the decision to treat have been delayed by the need of exclusion of other pathologies, principally tuberculosis reactivation/reinfection, other mycobacterial diseases, hematologic malignancies. We propose a simplified flowchart for diagnosis and follow up of sarcoidosis, which may also be applied to patients with HIV infection. Diagnosis of latent tuberculosis infection (LTBI) may be difficult in these patients, because the immunological paradox of sarcoidosis. For this reason, following exclusion of active tuberculosis, we advise to submit all sarcoidosis patients to IPT (isoniazid preventive therapy), when immunosuppressive therapy is started.
Keywords: Diagnostic flowchart; HIV infection; Sarcoidosis.
Figures
Similar articles
-
Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.BMC Infect Dis. 2015 Aug 26;15:368. doi: 10.1186/s12879-015-1085-7. BMC Infect Dis. 2015. PMID: 26306511 Free PMC article.
-
Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.AIDS. 2016 May 15;30(8):1279-86. doi: 10.1097/QAD.0000000000001078. AIDS. 2016. PMID: 26950316
-
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.Lancet Infect Dis. 2010 Jul;10(7):489-98. doi: 10.1016/S1473-3099(10)70078-5. Lancet Infect Dis. 2010. PMID: 20610331
-
Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.Proc Am Thorac Soc. 2011 Jun;8(3):288-93. doi: 10.1513/pats.201010-064WR. Proc Am Thorac Soc. 2011. PMID: 21653530 Free PMC article. Review.
-
Treatment guidelines for latent tuberculosis infection.Kekkaku. 2014 Jan;89(1):21-37. Kekkaku. 2014. PMID: 24654427 Review.
Cited by
-
The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients.J Res Med Sci. 2020 Mar 18;25:24. doi: 10.4103/jrms.JRMS_74_19. eCollection 2020. J Res Med Sci. 2020. PMID: 32419781 Free PMC article.
-
Lymphadenopathy and granulomas: benignancy of malignancy and differential diagnosis with endobronchial ultrasound-transbronchial needle biopsy 19G needle fine-needle aspiration biopsy.Lung Cancer Manag. 2021 May 26;10(3):LMT49. doi: 10.2217/lmt-2021-0002. eCollection 2021 Sep. Lung Cancer Manag. 2021. PMID: 34408790 Free PMC article.
References
-
- Almeida F.A., Sager J.S., Eiger G. Coexistent sarcoidosis and HIV infection: an immunological paradox? J. Infect. 2006 Mar;52(3):195–201. Epub 2005 Aug 3. - PubMed
-
- Badgwell C., Rosen T. Cutaneous Sarcoidosis therapy updated. J. Am. Acad. Dermatol. 2007;56(1):69–83. - PubMed
-
- Baughman R.P., Nunes H., Sweiss N.J., Lower E.E. Established and experimental medical therapy of pulmonary sarcoidosis. Eur. Respir. J. 2013;41(6):1424–1438. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials